Delivery Order SPE2DB24D1205-SPE2DB25FDAWX
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ayvakit 25 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $48,737.84, represents a non-set-aside competitive award and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packages) with a ceiling value of $97,475.68. This firm fixed price delivery order, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 18, 2025, provides for the supply of AYVAKIT 25 mg tablets (30-count units) valued at $24,368.92 with a completion date of September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA), which procures medical supplies for the Department of Defense. Performance will be conducted from the contractor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $24.4K and is structured as a firm fixed price delivery order, with an ultimate completion date of September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of Ayvakit 25 mg tablets, a specialty pharmaceutical product. The delivery order has a ceiling value of $46,651.36 and a performance period through April 1, 2024. This is a firm fixed price contract with no set-aside designation....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of AYVAKIT 25 MG tablets (30-count units) with a ceiling value of $73,106.76. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24,368.92 for AYVAKIT 25 mg tablets (30-count packaging) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive delivery order executed by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAWXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ayvakit 25 mg tablets (30-count units) with a ceiling value of $24,368.92. The contract employs firm fixed pricing with an ultimate completion date of October 20, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract reflects DLA's ongoing strategy to maintain reliable pharmaceutical supply chains through competitive procurement mechanisms with capable, established vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 9/26/25 |